Trial intelligence / Profile preview

Finasteride for Chronic Central Serous Chorioretinopathy

NCT00837252Phase 2Completed

Sponsor
National Eye Institute
Start
Feb 2009
Primary completion
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of finasteride in Central Serous Chorioretinopathy (CSCR), sponsored by National Eye Institute. Started Feb 2009; status: completed.

02

Drugs

finasteride
03

Conditions

Central Serous Chorioretinopathy (CSCR)

Beyond the preview

Go deeper on NCT00837252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00837252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call